ARHGEF3, a member of the Rho GEFs family, is highly expressed in non-small cell lung cancer, enhancing the protein stability of ACLY, thereby promoting the proliferation of NSCLC cells both in vitro and in vivo (Zhou et al., 2022). Here, ACLY is linked to non-small cell lung carcinoma.